IDH1 and glioblastoma: The first patient was a newly-diagnosed non-enhancing IDH-mut oligodendroglioma and demonstrated moderate normalized sodium signal intensity in areas of NET (Fig. 1A), while the second patient had a recurrent, contrast enhancing IDH-wt glioblastoma and demonstrated highest sodium in necrosis followed by CET and then NET (Fig. 1B).